Dr. Angela Y Jia, MD, PhD
Claim this profileCase Western Reserve University
Studies Prostate Cancer
Studies Prostate Adenocarcinoma
4 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Angela Y Jia, MD, PhD is currently running
Relugolix + Radiation
for Advanced-Stage Prostate Cancer
This phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with castration-sensitive prostate cancer that has spread to limited other parts of the body (oligometastatic). Relugolix is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body. It may stop the growth of cancer cells that need testosterone to grow. Radiation therapy uses high-energy x rays or protons to kill tumor cells. The addition of relugolix to the radiation may reduce the chance of oligometastatic prostate cancer spreading further.
Recruiting0 awards Phase 2
Shorter vs Usual Radiation Therapy
for Prostate Cancer
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
Recruiting2 awards Phase 310 criteria
More about Angela Y Jia, MD, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Angela Y Jia, MD, PhD has experience with
- Stereotactic Body Radiation Therapy
- Androgen Deprivation Therapy (ADT)
- Metastasis Directed Radiotherapy (MDRT)
- Lu-PSMA-617
- Stereotactic Body Radiation Therapy (SBRT)
- Relugolix
Breakdown of trials Angela Y Jia, MD, PhD has run
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Angela Y Jia, MD, PhD specialize in?
Angela Y Jia, MD, PhD focuses on Prostate Cancer and Prostate Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Angela Y Jia, MD, PhD currently recruiting for clinical trials?
Yes, Angela Y Jia, MD, PhD is currently recruiting for 4 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Angela Y Jia, MD, PhD has studied deeply?
Yes, Angela Y Jia, MD, PhD has studied treatments such as Stereotactic Body Radiation Therapy, Androgen deprivation therapy (ADT), Metastasis directed radiotherapy (MDRT).
What is the best way to schedule an appointment with Angela Y Jia, MD, PhD?
Apply for one of the trials that Angela Y Jia, MD, PhD is conducting.
What is the office address of Angela Y Jia, MD, PhD?
The office of Angela Y Jia, MD, PhD is located at: Case Western Reserve University, Cleveland, Ohio 44106 United States. This is the address for their practice at the Case Western Reserve University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.